Social Media Influencers Fueling Parallel Trade for Unapproved Slimming Drug
An underground market for unlicensed weight-loss medications is being driven by TikTok fitness influencers and sellers on communication apps, based on recent findings.
Experimental Drug Gaining Traction Via Social Media
Retatrutide, which remains in clinical trials, is being promoted by social media influencers for its alleged fat-burning properties. Viewers are urged to contact these profiles directly for source information, while also receiving discount codes.
Thriving Commerce on Social Networks
Additionally, a robust market exists on messaging services, where groups with thousands of participants share comparison photos, administration instructions and assertions of rapid British shipping. Vendors market the drug there before directing customers to other platforms for transactions.
Learning About The Experimental Drug
This medication is an investigational injectable created by US drugmaker Eli Lilly. The treatment affects three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could help patients reduce up to a quarter of their body weight. Referred to as the “triple G”, the drug is being hailed digitally as the successor to Ozempic.
Medical Experts Voice Concerns
However, doctors and pharmacists have warned that the sale of what is still an unlicensed drug in the UK is a cause for concern and could result in individuals injecting substances of unknown origin.
Several experts stated the demand for retatrutide could be connected to the rising cost of approved slimming treatments such as Mounjaro.
Regulatory Status and Implementation
Selling the unapproved drug on social media or messaging apps is illegal in the UK, as it is an unapproved drug that cannot be marketed or supplied for personal consumption under the Human Medicines Regulations 2012.
Several content creators attempt to circumvent the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but promotion and supply can still violate pharmaceutical, advertising, and customer regulations, risking fines, prosecution or imprisonment.
Platform Reaction and Material Removal
According to TikTok, the service has removed violative material and banned related keywords and query recommendations. The company stated it was committed to keeping the service safe and investing in strengthening compliance measures.
Online Trading Activities
Investigations also found groups with up to nine thousand participants marketing the experimental drug using Telegram's built-in discovery tool, which operates like a online catalog. Typing “retatrutide” immediately brings up channels with thousands of users, populated with photos of slimming results, positive testimonials and detailed instructions for preparing or injecting at home.
After minutes of joining one group, a seller posted contact information, where the majority of purchases occur. The vendor provided an instruction manual and promised shipping within two days. When questioned whether the product was genuine, one seller said: “You can’t be sure.” Another shared a image of a alleged laboratory certificate. Not one asked about body mass, health issues or previous experience.
Item Information and Pricing
Inside these groups, posts show black plastic parcels with Royal Mail stickers, stating to contain fresh supplies. One communication read: “It took eight of us to load them this morning.”
Buyers can choose between powder vials, mixed at residence with sterile water, or pre-filled injectors typically priced at 160 pounds for 20mg. When questioned how much time a pen should be used, vendors give conflicting responses varying between a few weeks to “depends on your body”.
Service Oversight and Security Actions
A representative for Telegram said it regularly moderated dangerous content on its platform including material that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.
Healthcare Professional Cautions
“People are administering substances they can’t verify. Although the science behind this drug is valid, these online products may not contain what they advertise,” stated a pharmacy expert, the director of pharmacy at a pharmacy service.
Dr Crystal Wyllie of an online medical service linked the surge in demand to recent price rises for approved slimming medications such as Mounjaro. “With prices rising, patients are using online platforms. But fake injections are highly dangerous. You cannot know what’s contained or whether the conditions they were made in was sterile,” she said.
Her staff has previously seen individuals injured by self-injection from unconfirmed sources. “We understand the frustration, but purchasing from Telegram or WhatsApp is taking chances with your health,” stated Wyllie. “These substances could be contaminated or incorrectly dosed.”
Manufacturer Statement
A representative from the pharmaceutical company stated the substance was in third stage clinical trials and had not been reviewed or approved by any government authority globally. “Consequently at this time no one can sell [it] for human use,” they said, noting that any item “falsely representing itself as a company experimental substance not yet authorized … may expose patients to possibly serious health risks”.
